Q&A With Paul Gurbel From Inova Health System: Examining the Benefits of Extended Release Aspirin
In the medical community there are many questions about the benefits of patients on a daily aspirin regimen and who should be considered for this treatment option. While these questions apply mainly to standard aspirin treatments currently available there is work being done to move the field in a new direction.
In the medical community there are many questions about the benefits of patients on a daily aspirin regimen and who should be considered for this treatment option. While these questions apply mainly to standard aspirin treatments currently available there is work being done to move the field in a new direction.
Paul A. Gurbel, MD, from Inova Health Systems discussed a new potential time released treatment which he said could prove beneficial for patients with diabetes and other conditions and also minimize the effect on the gastrointestinal system. Gurbel was one of thousands of health care professionals taking part in the American Heart Association's annual scientific sessions in Orlando.
